HSV-2 vaccine (Simplexia)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHSV-2 vaccine (Simplexia)
Drug Alias NameHSV-2 mature glycoprotein Ggenital herpes vaccine (Simplexia)mgG-2 protein
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSimplexia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSimplexia
Active IndicationsN/A
Inactive IndicationsHerpes Simplex Virus Type 2 Infections

Other Information

ATC CodeN/A
Related LinksN/A